Xenetic Biosciences Inc (XBIO) — Financial Flexibility Index
Xenetic Biosciences Inc (XBIO) has a Financial Flexibility Index of -0.59x as of September 2025. Free cash flow of $-658.24K (operating CF $-658.25K minus capex $3.00) represents -1% of total liabilities ($1.11 Million). Also explore XBIO net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Xenetic Biosciences Inc Financial Flexibility Index (2012–2024)
Historical Financial Flexibility Index trend for Xenetic Biosciences Inc across 13 annual periods. Check XBIO PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Xenetic Biosciences Inc (2012–2024)
Year-by-year free cash flow to debt coverage for Xenetic Biosciences Inc. For the full company profile including market capitalisation, see how much is Xenetic Biosciences Inc worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -3.15x | $-2.82 Million | $-2.82 Million | $894.26K | ▲ +38.0% |
| 2023 | -5.08x | $-4.11 Million | $-4.11 Million | $809.59K | ▼ -31.5% |
| 2022 | -3.86x | $-4.15 Million | $-4.65 Million | $1.07 Million | ▼ -15.9% |
| 2021 | -3.33x | $-4.74 Million | $-4.74 Million | $1.42 Million | ▲ +24.7% |
| 2020 | -4.43x | $-4.27 Million | $-4.27 Million | $963.97K | ▼ -199.8% |
| 2019 | -1.48x | $-6.40 Million | $-6.40 Million | $4.33 Million | ▼ -3.2% |
| 2018 | -1.43x | $-6.46 Million | $-6.46 Million | $4.52 Million | ▼ -562.7% |
| 2017 | 0.31x | $1.50 Million | $1.49 Million | $4.86 Million | ▲ +116.9% |
| 2016 | -1.83x | $-8.77 Million | $-8.79 Million | $4.80 Million | ▼ -254.8% |
| 2015 | -0.51x | $-5.30 Million | $-5.30 Million | $10.30 Million | ▲ +75.5% |
| 2014 | -2.10x | $-12.27 Million | $-12.33 Million | $5.84 Million | ▼ -141.1% |
| 2013 | -0.87x | $-5.97 Million | $-6.05 Million | $6.85 Million | ▲ +34.7% |
| 2012 | -1.34x | $-6.13 Million | $-6.26 Million | $4.59 Million | — |